These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15679050

  • 21. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
    Uchima Y, Sawada T, Nishihara T, Maeda K, Ohira M, Hirakawa K.
    Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
    [Abstract] [Full Text] [Related]

  • 22. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R.
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [Abstract] [Full Text] [Related]

  • 23. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway.
    Wang XF, Zhou QM, Du J, Zhang H, Lu YY, Su SB.
    Anticancer Agents Med Chem; 2013 Jul 01; 13(6):923-31. PubMed ID: 23387975
    [Abstract] [Full Text] [Related]

  • 24. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 01; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 25. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL, Roth M.
    J Cell Physiol; 2006 May 01; 207(2):540-52. PubMed ID: 16447244
    [Abstract] [Full Text] [Related]

  • 26. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH, Hyun MS, Kim JR.
    Clin Exp Metastasis; 2003 May 01; 20(6):499-505. PubMed ID: 14598883
    [Abstract] [Full Text] [Related]

  • 27. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
    Shin S, Kim MK, Jung W, Chong Y.
    Phytother Res; 2018 Oct 01; 32(10):2086-2096. PubMed ID: 30009577
    [Abstract] [Full Text] [Related]

  • 28. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
    Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D.
    Oncogene; 2001 Dec 06; 20(56):8066-74. PubMed ID: 11781819
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA.
    Mol Pharmacol; 2002 Jul 06; 62(1):58-64. PubMed ID: 12065755
    [Abstract] [Full Text] [Related]

  • 30. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
    Rucci N, Millimaggi D, Mari M, Del Fattore A, Bologna M, Teti A, Angelucci A, Dolo V.
    Cancer Res; 2010 Aug 01; 70(15):6150-60. PubMed ID: 20631064
    [Abstract] [Full Text] [Related]

  • 31. Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition.
    Merrell M, Suarez-Cuervo C, Harris KW, Väänänen HK, Selander KS.
    Breast Cancer Res Treat; 2003 Oct 01; 81(3):231-41. PubMed ID: 14620918
    [Abstract] [Full Text] [Related]

  • 32. Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells.
    Chen J, Baskerville C, Han Q, Pan ZK, Huang S.
    J Biol Chem; 2001 Dec 21; 276(51):47901-5. PubMed ID: 11606583
    [Abstract] [Full Text] [Related]

  • 33. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
    Kim HS, Luo L, Pflugfelder SC, Li DQ.
    Invest Ophthalmol Vis Sci; 2005 Mar 21; 46(3):840-8. PubMed ID: 15728539
    [Abstract] [Full Text] [Related]

  • 34. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
    Chen HJ, Lin CM, Lee CY, Shih NC, Peng SF, Tsuzuki M, Amagaya S, Huang WW, Yang JS.
    Oncol Rep; 2013 Aug 21; 30(2):925-32. PubMed ID: 23708932
    [Abstract] [Full Text] [Related]

  • 35. Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.
    Mandel K, Seidl D, Rades D, Lehnert H, Gieseler F, Hass R, Ungefroren H.
    PLoS One; 2013 Aug 21; 8(2):e56591. PubMed ID: 23457587
    [Abstract] [Full Text] [Related]

  • 36. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC.
    Exp Cell Res; 2003 Nov 15; 291(1):1-10. PubMed ID: 14597403
    [Abstract] [Full Text] [Related]

  • 37. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
    Kim ES, Kim MS, Moon A.
    Int J Oncol; 2004 Nov 15; 25(5):1375-82. PubMed ID: 15492828
    [Abstract] [Full Text] [Related]

  • 38. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
    Li CC, Yao HT, Cheng FJ, Hsieh YH, Lu CY, Wu CC, Liu KL, Chang JW.
    Nutr Cancer; 2015 Nov 15; 67(5):771-82. PubMed ID: 25970488
    [Abstract] [Full Text] [Related]

  • 39. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.
    Breast Cancer Res Treat; 2011 Apr 15; 126(2):373-84. PubMed ID: 20464481
    [Abstract] [Full Text] [Related]

  • 40. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes.
    Santibáñez JF, Iglesias M, Frontelo P, Martínez J, Quintanilla M.
    Biochem Biophys Res Commun; 2000 Jul 05; 273(2):521-7. PubMed ID: 10873638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.